To evaluate the occurrence and clinical role of active parvovirus B19 infection in solid organ
and bone marrow transplant recipients, 256 serum samples from 212 transplant patients …

Objective To study parvovirus B19 infection in immunocompromised subjects such as renal
transplantation recipients. Methods Two cases of B19 infection in renal transplant recipients …

Human parvovirus B19 can persist in immunocompromised patients and may produce
severe clinical illness. In this retrospective study the incidence of B19-associated infections …

Renal transplant patients were screened for the presence of parvovirus B19, before
transplantation and monthly for 4 months after transplantation, by means of a sensitive …

Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was
performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates …

Human parvovirus B19 (B19) infection has been known to cause chronic anemia, pure red
cell aplasia (PRCA), glomerulopathy, and allograft dysfunction in kidney transplant (KT) …

Due to the preparative regimen necessary, bone marrow transplantation (BMT) consistently
results in severe immunodeficiency, often associated with anaemia, leukopenia and …

Background: Clinical manifestations of parvovirus B19 infection in immunocompromised
patients are mostly reported as acute or chronic hematologic disorders. More recently …

Five hundred thirty-three liver transplant recipients were seen for follow-up care over a 6-
month period. Of these, 23 (4.3%) had a hemoglobin level of< or= 9 g/dl, with 19 being …

We report a 61‐yr‐old kidney transplant recipient with human Parvovirus B19 (HPV B19)
infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow …